Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9900
+0.0091 (0.93%)
Oct 28, 2026, 4:00 PM EDT - Market closed
Cocrystal Pharma Revenue
Cocrystal Pharma had revenue of $105.00K in the quarter ending June 30, 2026. That makes Cocrystal Pharma the 44,978th largest company in the world by revenue and 6,462nd in the United States.
Revenue (ttm)
$330.00K
Revenue Growth
n/a
P/S Ratio
57.79
Revenue / Employee
$33,000
Employees
10
Market Cap
19.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 2.01M | -4.55M | -69.32% |
| Dec 31, 2019 | 6.56M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 78.00K | 69.00K | 766.67% |
| Dec 31, 2014 | 9.00K | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 12.61M | -2.65M | -17.36% |
| Dec 31, 2010 | 15.25M | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kyntra Bio | 4.62M |
| Marker Therapeutics | 3.55M |
| Seres Therapeutics | 1.88M |
| BeyondSpring | 1.88M |
| Neuphoria Therapeutics | 1.17M |
COCP News
- 7 weeks ago - Cocrystal Pharma doses last subject in norovirus challenge study - TheFly
- 7 weeks ago - Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment - GlobeNewsWire
- 2 months ago - Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - GlobeNewsWire
- 2 months ago - Cocrystal Pharma announces $5M investment from Opko Health - TheFly
- 2 months ago - Cocrystal Pharma announces $5M private placement with Opko Health - TheFly
- 2 months ago - Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health - GlobeNewsWire
- 4 months ago - Cocrystal co-CEOs Sam Lee and Jim Martin step down, James Sapirstein succeeds - TheFly
- 4 months ago - Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer - GlobeNewsWire